<DOC>
	<DOC>NCT01062074</DOC>
	<brief_summary>This survey is conducted for preparing application materials for re-examination under the Pharmaceutical Affairs Laws and its Enforcement Regulation, its aim is to reconfirm the clinical usefulness of Gardasil through collecting the safety information according to the Re-examination Regulation for New Drugs.</brief_summary>
	<brief_title>GARDASIL Reexamination Study (V501-059)</brief_title>
	<detailed_description />
	<criteria>Females and males 926 years of age who Are Vaccinated With The First Dose Of Gardasil For The Prevention Of Any Disease Caused By Human Papillomavirus (e.g., Cervical Cancer, Genital Warts, etc.) Within Local Labeling Participant Who Has A Contraindication To Gardasil According To The Local Label Participants Who Are Vaccinated With Gardasil Before Study Start</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>26 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>